Trial Search Results

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Columbia University

Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)

Stanford Investigator(s):


Inclusion Criteria:

   - Patients diagnosed with or suspected to have a mitochondrial disorder

   - Adult carriers of known mitochondrial DNA mutations

   - Patients with laboratory analysis indicative of a mitochondrial disorder.

   - Medical information and tissue samples are also accepted from deceased individuals who
   fulfill the above criteria.

Exclusion Criteria:

   - Patients not suspected of having a mitochondrial disorder

   - Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that
   affects mitochondrial function.

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Gregory Enns, MD